- Weitere Titel
-
Stärkung der T Zell Funktion in Tumoren mit hoher glykolytischer Aktivität
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Regensburg, Universität Regensburg, Dissertation, 2022
- Schlagwort
-
Immunreaktion
T-Lymphozyt
- Ereignis
-
Veröffentlichung
- (wo)
-
Regensburg
- (wer)
-
Universitätsbibliothek Regensburg
- (wann)
-
2023
- Urheber
-
Decking, Sonja
- Beteiligte Personen und Organisationen
-
Kreutz, Marina
- URN
-
urn:nbn:de:bvb:355-epub-518664
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Decking, Sonja
- Kreutz, Marina
- Universitätsbibliothek Regensburg
Entstanden
- 2023
Ähnliche Objekte (12)
BRG1 improves reprogramming efficiency by enhancing glycolytic metabolism
PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism
Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
Rapid glycolytic activation accompanying innate immune responses: mechanisms and function
Ucp1 Ablation Improves Skeletal Muscle Glycolytic Function in Aging Mice
Autophagy regulator ATG5 maintains cerebellar function by preventing excessive glycolytic activity
Enhancing circadian clock function in cancer cells inhibits tumor growth
Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways
TAB182 regulates glycolytic metabolism by controlling LDHA transcription to impact tumor radiosensitivity
Erratum to: Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
BRG1 improves reprogramming efficiency by enhancing glycolytic metabolism
PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism
Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
Rapid glycolytic activation accompanying innate immune responses: mechanisms and function
Ucp1 Ablation Improves Skeletal Muscle Glycolytic Function in Aging Mice
Autophagy regulator ATG5 maintains cerebellar function by preventing excessive glycolytic activity
Enhancing circadian clock function in cancer cells inhibits tumor growth
Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways
TAB182 regulates glycolytic metabolism by controlling LDHA transcription to impact tumor radiosensitivity
Erratum to: Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
Mediation of PKM2-dependent glycolytic and non-glycolytic pathways by ENO2 in head and neck cancer development
BRG1 improves reprogramming efficiency by enhancing glycolytic metabolism
PRMT3 drives glioblastoma progression by enhancing HIF1A and glycolytic metabolism
Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma
Rapid glycolytic activation accompanying innate immune responses: mechanisms and function
Ucp1 Ablation Improves Skeletal Muscle Glycolytic Function in Aging Mice
Autophagy regulator ATG5 maintains cerebellar function by preventing excessive glycolytic activity
Enhancing circadian clock function in cancer cells inhibits tumor growth
Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth
HK2: a potential regulator of osteoarthritis via glycolytic and non-glycolytic pathways
TAB182 regulates glycolytic metabolism by controlling LDHA transcription to impact tumor radiosensitivity
Erratum to: Inhibition of glycolytic enzyme hexokinase II (HK2) suppresses lung tumor growth